| [1] |
Rustogi A, Budrukkar A, Dinshaw K, et al. Management of locally advanced breast cancer: evolution and current practice.J Cancer Res Ther,2005,1:21 -30.
|
| [2] |
包迎红,潘峰,周成槎. 温州市鹿城区2003 ～2005年新发肿瘤发病分析.中华肿瘤防治杂志,2006,13:1449 -1451.
|
| [3] |
王琳. 上海市杨浦区1983 ～2001年常见恶性肿瘤发病趋势.中国肿瘤,2004,13:694 -695.
|
| [4] |
Anees B C,Jamine L S,Charles R S, et al. Factors associated with surgical options for breast carcinoma. Cancer,2006,106:1462 -1466.
|
| [5] |
Chen A M, Meric Bernstam F, Hunf K K, et al. Breast conservation after neoadjuvant chemotherapy:the MD Anderson cancer center experience.J Clin Oncol.2004,15,22:2303-2312.
|
| [6] |
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med,2002,347:1233 -1241.
|
| [7] |
Singletary S E. Breast cancer surgery for the 21st century: the continuing evolution of minimally invasive treatment. Minerva Chir,2006,61:333 -352.
|
| [8] |
American College of Radiology. Practice guideline for the breast conservation therapy in the management of invasive breast carcinoma. J Am Coll Surg,2007,205:362 -376.
|
| [9] |
Kaufmann P, Dauphine C E, Vargas M P, et al. Success of neoadjuvant chemotherapy in conversion of mastectomy to breast conservation surgery. Am Surg,2006,72:935 -938.
|
| [10] |
Chen C Y, Sun L M, Anderson B O. Paget disease of the breast: changing patterns of incidence,clinical presentation,and treatment in the U.S. Cancer,2006,107:1448 -1458.
|
| [11] |
张保宁,邵志敏,乔新民,等.中国乳腺癌保乳治疗的前瞻性多中心研究.中华肿瘤杂志,2005,27:680 -684.
|
| [12] |
王永胜,左文述,刘娟娟,等.乳腺癌前哨淋巴结活检替代腋窝清扫术前瞻性非随机对照临床研究. 外科理论与实践,2006,11:104 -107.
|
| [13] |
Rosing D K, Dauphine C E, Vargas M P, et al. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer. Am Surg,2006,72:939 -942.
|
| [14] |
Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 2003,349:546 -553.
|
| [15] |
Froud P J, Mates D, Jackson J S, et al. Efceft of time interval between breast conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys,2000,46:363 -372.
|
| [16] |
Faul C, Brufsky A, Gerszten K, et al. Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no efceft on treatment delivery. Eur J Cancer,2003,39:763 -768.
|
| [17] |
修霞, Tripuraneni Prabhakar, Giap Huan Lin Ray,等.早期乳腺癌保乳术后部分乳腺高剂量率后装加速照射的毒性反应及美容效果. 中华放射肿瘤学杂志,2007,16:25 -29.
|
| [18] |
DiFronzo L A, Tsai P I, Hwang J M, et al. Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience. Arch Surg,2005,140:787 -794.
|
| [19] |
江泽飞,宋三泰.蒽环类化疗药物治疗乳腺癌的新动向. 中华肿瘤杂志,2005,27:193 -195.
|
| [20] |
Heller W, Mazhar D, Ward R, et al. Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer. Oncol Rep,2007,17:253 -259.
|
| [21] |
Gonzalez-Angulo A M, Morales Vasquez F, Hortobagyi G N.Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol,2007,608:1 -22.
|
| [22] |
Fisher B, Jeong J H, Bryant J, et al. Bulmpact of systemic treatment on local control for patients with lymphnode negative breast cancer treated with breast conservation therapy. J Clin Oncol,2001,19:2240.
|
| [23] |
张斌.乳腺癌新辅助内分泌治疗.中国癌症杂志,2006,16 :689 -692.
|
| [24] |
秦玉坤,李维廉.芳香化酶抑制剂在乳腺癌新辅助治疗中的研究进展. 临床外科杂志,2006,14:32 -33.
|
| [25] |
Thomas J S, Julian H S, Green R V, et al. Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring. Histopathology,2007,51:219 -226.
|
| [26] |
Gage I, Schnitt S J, Nixon A J, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer,1996,78:1921 -1928.
|